James G. Bender - Net Worth and Insider Trading

James G. Bender Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James G. Bender owns 2 companies in total, including Iovance Biotherapeutics Inc (IOVA) , and EOM Pharmaceutical Holdings Inc (IMUC) .

Click here to see the complete history of James G. Bender’s form 4 insider trades.

Insider Ownership Summary of James G. Bender

Ticker	Comapny	Transaction Date	Type of Owner
IOVA	Iovance Biotherapeutics Inc	2014-01-06	Vice President & Manufacturing
IMUC	EOM Pharmaceutical Holdings Inc	2013-08-28	VP & Product Development & Mfg.

James G. Bender Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James G. Bender Ownership Network

Ownership Network List of James G. Bender

No Data

Ownership Network Relation of James G. Bender

James G. Bender Owned Company Details

What does Iovance Biotherapeutics Inc do?

Who are the key executives at Iovance Biotherapeutics Inc?

James G. Bender is the Vice President & Manufacturing of Iovance Biotherapeutics Inc. Other key executives at Iovance Biotherapeutics Inc include General Counsel Frederick G Vogt , Chief Operating Officer Igor Bilinsky , and Chief Financial Officer Jean-marc Bellemin .

Iovance Biotherapeutics Inc (IOVA) Insider Trades Summary

Over the past 18 months, James G. Bender made no insider transaction in Iovance Biotherapeutics Inc (IOVA). Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchase of 290,000 shares made by Merrill A Mcpeak , a net purchase of 20,000,000 shares made by Wayne P. Rothbaum , and a net purchase of 10,000 shares made by Iain D. Dukes .

In summary, during the past 3 months, insiders sold 0 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 20,301,000 shares were bought by its insiders, resulting in a net purchase of 20,301,000 shares.

Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Iovance Biotherapeutics Inc Insider Transactions

No Available Data

James G. Bender Mailing Address

Above is the net worth, insider trading, and ownership report for James G. Bender. You might contact James G. Bender via mailing address: 112 West 34th Street, 17th Floor, New York Ny 10120.

Discussions on James G. Bender

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.